Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at 0 times
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
High Debt company with Weak Long Term Fundamental Strength
3
Flat results in Dec 24
4
With ROCE of 4.7, it has a very expensive valuation with a 1.9 Enterprise value to Capital Employed
Stock DNA
Medical/Nursing Services
JPY 34,424 Million (Large Cap)
43.00
NA
0.00%
0.79
6.19%
2.63
Revenue and Profits:
Net Sales:
5,077 Million
(Quarterly Results - Dec 2024)
Net Profit:
430 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.14%
0%
-0.14%
6 Months
9.07%
0%
9.07%
1 Year
52.21%
0%
52.21%
2 Years
48.01%
0%
48.01%
3 Years
39.64%
0%
39.64%
4 Years
16.98%
0%
16.98%
5 Years
29.53%
0%
29.53%
I'rom Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.66%
EBIT Growth (5y)
3.69%
EBIT to Interest (avg)
17.26
Debt to EBITDA (avg)
3.04
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.61
Tax Ratio
48.47%
Dividend Payout Ratio
34.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.17%
ROE (avg)
16.05%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.63
EV to EBIT
40.34
EV to EBITDA
19.59
EV to Capital Employed
1.91
EV to Sales
2.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.74%
ROE (Latest)
6.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ
Dec'24
Sep'24
Change(%)
Net Sales
5,077.00
4,214.00
20.48%
Operating Profit (PBDIT) excl Other Income
962.00
259.00
271.43%
Interest
54.00
53.00
1.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
430.00
-356.00
220.79%
Operating Profit Margin (Excl OI)
137.90%
-7.80%
14.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2024 is 20.48% vs -8.71% in Sep 2024
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2024 is 220.79% vs -222.34% in Sep 2024
Annual Results Snapshot (Consolidated) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
17,740.00
18,351.00
-3.33%
Operating Profit (PBDIT) excl Other Income
2,271.00
4,296.00
-47.14%
Interest
178.00
146.00
21.92%
Exceptional Items
-1.00
1.00
-200.00%
Consolidate Net Profit
1,415.00
2,553.00
-44.58%
Operating Profit Margin (Excl OI)
64.00%
190.70%
-12.67%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2024 is -3.33% vs 16.94% in Mar 2023
Consolidated Net Profit
YoY Growth in year ended Mar 2024 is -44.58% vs 30.59% in Mar 2023
About I'rom Group Co., Ltd. 
I'rom Group Co., Ltd.
Medical/Nursing Services
No Details Available.
Company Coordinates 
No Company Details Available






